Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART

Colaboración

Año: 2016

Palacios, R; Perez-Hernandez, IA; Martinez, MA; Mayorga, ML; Gonzalez-Domenech, CM; Omar, M; Olalla, J; Romero, A; Romero, JM; Perez-Camacho, I; Hernandez-Quero, J; Santos, J

Título: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

• Q2